26 results
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... lung disease (ILD ... #lungdisease #ILD ... systemicsclerosis #SSc #pulmonary ... #treatment #algorithm
Causes of Interstitial Lung Disease - Differential Diagnosis Algorithm
Idiopathic Interstitial Pneumonia
 • (UIP) Usual Interstitial Pneumonia
Differential Diagnosis Algorithm ... this should be 1° ... leaking out of pulmonary ... Chronic Radiation Pneumonitis ... #ILD #Causes #Differential
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
expiratory volume in 1  ... s; IL: interleukin ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
, Severe Valve Disease ... • Obstructive: Pulmonary ... Goals: 1) MAP ... #criticalcare #algorithm ... #treatment #management
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... Obstructive Lung Disease ... expiratory volume in 1  ... #Management #Pulmonary
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... limitation (GOLD Ill ... panel) • Alpha 1 ... #COPD #AECOPD #Algorithm ... #treatment #pulmonary
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... Pathophysiology: 1. ... Pneumonitis 3. ... Lung Abscess Management ... Lung #Abscess #pulmonary
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Definition: 
 • Severe adverse drug reaction, characterized by
for Diagnosis: 1. ... withdrawal • Mild ... treatment • Severe ... disease: 1. ... SinaiBmoreIMRes #DRESS #Syndrome
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Macrophage Activation Syndrome ... highly inflammatory disease ... -1 and IL-6, leading ... Treatment: • Corticosteroids ... #Diagnosis #Management
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
Hepatopulmonary Syndrome ... diffusion-perfusion defect (Type 1) ... ) on room air Treatment ... hepatopulmonary #syndrome ... #treatment #hepatology